CAS 925681-61-4

Trabedersen

Description:

Trabedersen, also known by its chemical designation and CAS number 925681-61-4, is an investigational therapeutic agent primarily studied for its potential in treating various types of cancer. It functions as an antisense oligonucleotide, designed to inhibit the expression of specific genes associated with tumor growth and progression. The mechanism of action involves binding to complementary RNA sequences, thereby preventing translation and reducing the production of target proteins that may contribute to malignancy. Trabedersen has been evaluated in clinical trials, particularly for its efficacy in conditions such as pancreatic cancer and other solid tumors. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for understanding its therapeutic potential and safety profile. As with many investigational drugs, ongoing research aims to elucidate its full range of biological effects, optimal dosing regimens, and potential side effects. Overall, Trabedersen represents a novel approach in the field of targeted cancer therapies, highlighting the role of genetic modulation in oncology.

Formula: Unspecified

Synonyms:

• OT 101
• DNA, d(P-thio)(C-G-G-C-A-T-G-T-C-T-A-T-T-T-T-G-T-A)
• Trabedersen
• AP 12009